Biofrontera Pharmaceuticals Holding AG, DNAPrint deal

DNAP will invest E20 million ($24.5 million) over the next two years for a 51.4% stake in Biofrontera in the form of series B shares. The companies also entered a JV to integrate Biofrontera's drug di...